M&A
Standard Life, Aberdeen merger gets green light from UK regulators
Standard Life's £11bn merger with Aberdeen Asset Management has been given the green light by UK regulators.
Michael Kors to buy Jimmy Choo for £896m
Fashion brand Micheal Kors has agreed to buy Jimmy Choo for £896m.
Paysafe announces acquisition and possible GBP2.8bn takeover offer
In an unusual double, Paysafe Group has both struck a $470m deal to acquire US-based Merchants' Choice Payment and also announced that it has received a takeover proposal from private equity companies Blackstone and CVC Capital Partners.
Reckitt Benckiser agrees USD4.2bn sale of food business to McCormick
Reckitt Benckiser has agreed to sell its food business for $4. 2bn (£3. 2bn) to Schwartz spices owner McCormick.
TT Electronics offloads division to AVX
TT Electronics hived off its Transportation Sensing and Control arm in order to pay down debt and fund future growth and acquisitions.
GlaxoSmithKline said to consider sale of Horlicks in the UK
GlaxoSmithKline was in focus on Wednesday amid reports the pharmaceuticals giant is looking to sell off its Horlicks business.
Bain and Cinven sweeten offer for Stada
Private equity firms Bain Capital and Cinven have sweetened their offer for German pharmaceutical group Stada.
Church & Dwight to buy Water Pik for $1bn in cash
Church & Dwight has agreed to buy waterjet technology company Water Pik for around $1bn in cash.
UDG Healthcare buys US-based Cambridge BioMarketing for up to $35m
UDG Healthcare has announced the acquisition of US-based healthcare communications business Cambridge BioMarketing for up to $35m.
Sports Direct takes 26% stake in Game Digital
Sports Direct has bought 44m shares in video game retailer Game Digital, equivalent to a stake of 25. 8%, just weeks after a profit warning sent the stock tumbling more than 30%.
HSBC optimistic on outcome of CMA review of Tesco/Booker tie-up
HSBC sounded an optimistic note following the competition regulator's announcement that it had referred Tesco's acquisition of Booker for a Phase 2 review.
Rumours resurface of takeover bid for Spire Healthcare
Spire Healthcare is now in the crosshairs of its major shareholder, Mediclinic International, according to a report.
Dalian Wanda sells majority stake to rival Sunac China for $9.3bn
The Hong Kong-traded shares of Wanda Hotel Development shot up 145% on Monday morning on news that Chinese property giant Dalian Wanda Group would sell a majority stake in many of its theme parks and hotels in the country to rival developer Sunac China for $9. 3bn.
Bain, Cinven to sweeten Stada offer to €66.25 a share
Stada said on Monday that private equity firms Bain Capital and Cinven are prepared to raise their offer for the German pharmaceutical group.
Whole Foods spurned higher rival offers for Amazon takeover, filings show
Whole Foods attempts to drive a higher takeover price from Amazon. com were squished by the online giant's corporate brinksmanship, in spite of potential higher counter-bids from other companies and private equity firms.
Centrica surges as takeover rumours bubble
Shares in Centrica, the owner of British Gas, were cooking on gas on Friday sparked by whispers of a takeover.
Biffa aquires rival O'Brien for £35.2m in cash
Biffa announced Wednesday completion of the acquisition of O'Brien Waste Recycling Solutions Holding.
Worldpay tanks as JPMorgan quashes hopes of bidding war
Shares in London-listed payments processor Worldpay fell sharply on Wednesday after JPMorgan Chase Bank quashed any hopes investors might have had of a bidding war by saying it does not intend to make an offer for the company.
Worldpay rockets as it confirms approaches from Vantiv and JPMorgan
Shares in Worldpay rocketed on Tuesday after the payments processor confirmed that it has received preliminary approaches from US-based payment processing and technology provider Vantiv Inc and JPMorgan Chase Bank over a potential acquisition.
Hornby urges shareholders to reject Phoenix offer
AIM-listed model train set maker Hornby reiterated on Tuesday that the offer made by its largest shareholder, Phoenix Asset Management, "significantly undervalues" the company and its prospects.